4.7 Article

Prelamin A impairs 53BP1 nuclear entry by mislocalizing NUP153 and disrupting the Ran gradient

期刊

AGING CELL
卷 15, 期 6, 页码 1039-1050

出版社

WILEY-BLACKWELL
DOI: 10.1111/acel.12506

关键词

53BP1; cytoplasmic-nuclear trafficking; NUP153; prelamin A; Ran gradient; vascular disease

资金

  1. British Heart Foundation [RG/11/14/29056]
  2. Medical Research Council, UK [MR/L019116/1]
  3. Cancer Research UK Program [C6/A11224]
  4. European Research Council
  5. European Community Seventh Framework Programme [HEALTH-F2-2010-259893]
  6. CRUK [C6946/A14492]
  7. Wellcome Trust [WT092096]
  8. University of Cambridge, UK
  9. MRC [MR/L019116/1] Funding Source: UKRI
  10. British Heart Foundation [RG/11/14/29056] Funding Source: researchfish
  11. Cancer Research UK [11224, 18796] Funding Source: researchfish
  12. Medical Research Council [MR/L019116/1] Funding Source: researchfish

向作者/读者索取更多资源

The nuclear lamina is essential for the proper structure and organization of the nucleus. Deregulation of A-type lamins can compromise genomic stability, alter chromatin organization and cause premature vascular aging. Here, we show that accumulation of the lamin A precursor, prelamin A, inhibits 53BP1 recruitment to sites of DNA damage and increases basal levels of DNA damage in aged vascular smooth muscle cells. We identify that this genome instability arises through defective nuclear import of 53BP1 as a consequence of abnormal topological arrangement of nucleoporin NUP153. We show for the first time that this nucleoporin is important for the nuclear localization of Ran and that the deregulated Ran gradient is likely to be compromising the nuclear import of 53BP1. Importantly, many of the defects associated with prelamin A expression were significantly reduced upon treatment with Remodelin, a small molecule recently reported to reverse deficiencies associated with abnormal nuclear lamina.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据